source
- Former Galapagos CEO Paul Stoffels aims to revive cell therapy projects at new biotech Armed CellPaul Stoffels, who recently stepped down as chief executive of Belgian drug developer Galapagos, is turning his attention to cell‑based therapies. After leaving Galapagos last year, Stoffels has j…
- Experts call for Congress to create a dedicated regulatory framework for AI models used in academic medical centersOn Oct. 15, 2026, several health policy experts voiced support for a new regulatory approach specifically aimed at clinical artificial‑intelligence models that are developed and deployed in academi…